September 27, 2023 12:48 PM EDT

Boehringer agrees to comply with CMS' price negotiations over blockbuster Jardiance

Zachary Brennan

Senior Editor

Boehringer Ingelheim said Wednesday that it will take part in the first round of price negotiations with the Centers for Medicare and Medicaid Services for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Boehringer agrees to comply with CMS' price negotiations over blockbuster Jardiance

Zachary Brennan

Senior Editor

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Novartis won bidding war for kidney drug as Regulus' top three execs expect to make over $100M combined

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

RFK Jr. ends annual Covid vaccine recommendations for kids, pregnant women

Biogen taps City Therapeutics in RNAi deal worth up to $1B

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Boehringer agrees to com­ply with CM­S' price ne­go­ti­a­tions over block­buster Jar­diance

Senior Editor

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Boehringer agrees to comply with CMS' price negotiations over blockbuster Jardiance